Holen Sie sich die Stockscreener-App
2.92
3.31%
-0.10
InspireMD Inc. Aktie (NSPR) Neueste Nachrichten
InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - Defense World
InspireMD appoints Scott R. Ward to its Board - Medical Buyer
InspireMD adds medtech veteran Scott Ward to its board By Investing.com - Investing.com Nigeria
InspireMD Appoints Scott R. Ward to Board of Directors - Defense World
InspireMD, Inc. Appoints Scott R. Ward to Its Board of Directors - Marketscreener.com
InspireMD adds medtech veteran Scott Ward to its board - Investing.com
InspireMD Strengthens Leadership with Scott R. Ward Appointment - TipRanks
InspireMD Announces Appointment of Accomplished Medical - GlobeNewswire
InspireMD Strengthens Board with Ex-Medtronic Executive Ahead of CGuard Prime FDA Decision | NSPR Stock News - StockTitan
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World
StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - MarketBeat
InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates - MSN
InspireMD Inc (NSPR) Quarterly 10-Q Report - Quartzy
InspireMD Third Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.15 loss in 3Q 2023) - Yahoo Finance
InspireMD, Inc. (NASDAQ:NSPR) Q3 2024 Earnings Call Transcript - Insider Monkey
InspireMD Inc. Faces Financial Uncertainty Amidst Ongoing Losses and Cash Flow Challenges - TipRanks
InspireMD Inc. Reports Q3 2024 Financial Results - TipRanks
InspireMD Achieves Record Q3 Revenue with CGuard Success - TipRanks
InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
InspireMD Sets Revenue Record, Files FDA Approval for CGuard Stent Amid Wider Losses | NSPR Stock News - StockTitan
InspireMD Inc (NSPR) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Costs and ... By GuruFocus - Investing.com Canada
What To Expect From InspireMD Inc (NSPR) Q3 2024 Earnings - Yahoo Finance
InspireMD announces inducement grants - Medical Buyer
InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com - MarketBeat
Inspiremd Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - XM
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
InspireMD (NSPR) to Release Quarterly Earnings on Tuesday - MarketBeat
InspireMD to Report Third Quarter 2024 Financial Results - GlobeNewswire
InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th - The Manila Times
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - MarketBeat
Rosalind Advisors, Inc. Acquires Shares in InspireMD Inc - GuruFocus.com
One InspireMD Insider Raised Stake By 13% In Previous Year - Yahoo Finance
InspireMD (NYSE:NSPR) Research Coverage Started at StockNews.com - MarketBeat
10+ things to know in #MiamiTech: News from InspireMD, 1NCE, Flow, UrbanLink, Carve Communications, Miami Dade College, Aleph, Taxfyleand lots of opportunities! - Refresh Miami
InspireMD Expands with New Miami Headquarters - TipRanks
InspireMD Announces Establishment of Global Headquarters in - GlobeNewswire
InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System - StockTitan
InspireMD Gains FDA Premarket Approval for CGuard Prime Carotid Stent - Yahoo Finance
InspireMD (NSPR) Price Target Increased by 11.49% to 4.95 - MSN
InspireMD (NYSE:NSPR) Receives New Coverage from Analysts at StockNews.com - MarketBeat
InspireMD Advances with FDA Study Approval and Global Goals - Yahoo Finance
FDA approves InspireMD's pivotal carotid stent study - Investing.com
FDA approves InspireMD's pivotal carotid stent study By Investing.com - Investing.com Australia
InspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System - The Manila Times
InspireMD Announces Approval of Investigational Device - GlobeNewswire
Recent Investment Analysts’ Ratings Updates for InspireMD (NSPR) - Defense World
InspireMD Launches New Employee Inducement Plan - Investing.com
InspireMD Launches 2024 Plan to Attract Talent with Stock - TipRanks
Nantahala Capital Management LLC Sells 39,856 Shares of InspireMD, Inc. (NYSE:NSPR) - Defense World
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):